Alkermes plc [ALKS] stock prices are up 0.11% to $28.52 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The ALKS shares have gain 1.71% over the last week, with a monthly amount glided 1.13%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alkermes plc [NASDAQ: ALKS] stock has seen the most recent analyst activity on November 11, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $50. Previously, RBC Capital Mkts upgraded its rating to Outperform on September 26, 2025, and kept the price target unchanged to $44. On September 03, 2025, Wells Fargo initiated with an Overweight rating and assigned a price target of $44 on the stock. Goldman started tracking the stock assigning a Buy rating and suggested a price target of $43 on July 15, 2025. UBS upgraded its rating to a Buy but $42 remained the price target by the analyst firm on June 17, 2025. Needham started tracking with a Buy rating for this stock on May 28, 2025, and assigned it a price target of $45. In a note dated March 13, 2025, RBC Capital Mkts initiated an Sector Perform rating and provided a target price of $40 on this stock.
The stock price of Alkermes plc [ALKS] has been fluctuating between $25.17 and $36.45 over the past year. Currently, Wall Street analysts expect the stock to reach $46.57 within the next 12 months. Alkermes plc [NASDAQ: ALKS] shares were valued at $28.52 at the most recent close of the market. An investor can expect a potential return of 63.29% based on the average ALKS price forecast.
Analyzing the ALKS fundamentals
The Alkermes plc [NASDAQ:ALKS] reported sales of 1.52B for trailing twelve months, representing a surge of 4.24%. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.26%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.21 and Total Capital is 0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 28.35 points at the first support level, and at 28.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.72, and for the 2nd resistance point, it is at 28.92.
Ratios To Look Out For
It’s worth pointing out that Alkermes plc [NASDAQ:ALKS]’s Current Ratio is 3.67. On the other hand, the Quick Ratio is 3.27, and the Cash Ratio is 1.3. Considering the valuation of this stock, the price to sales ratio is 3.10, the price to book ratio is 2.72 and price to earnings (TTM) ratio is 14.11.
Transactions by insiders
Recent insider trading involved Hopkinson Craig C., EVP R&D, Chief Medical Officer, that happened on Dec 03 ’25 when 3748.0 shares were sold. Officer, Hopkinson Craig C. completed a deal on Dec 03 ’25 to buy 3748.0 shares. Meanwhile, EVP R&D, Chief Medical Officer Hopkinson Craig C. sold 4000.0 shares on Dec 01 ’25.
